Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: Effect of diabetes in type 1 and type 2 diabetic rat models

Endothelium: Journal of Endothelial Cell Research

Volumn 10, Issue 2, 2003, Pages 89-94

  Coppey, Lawrence J ^a,b   Gellett, Jill S ^a,b   Yorek, Mark A ^a,b  

^a Diabetes Endocrinology Researh Ctr   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Acetylcholine; Diabetes; Endothelium derived hyperpolarizing factor (EDHF); Nitric Oxide (NO); Vasodilation

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLUCOSE; NITRIC OXIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LEAN BODY WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCIATIC NERVE; STREPTOZOCIN DIABETES; VASCULARIZATION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; BIOLOGICAL FACTORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; INDOMETHACIN; MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; SCIATIC NERVE; VASODILATION;

ANIMALIA;

EID: 0042065403     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320303366     Document Type: Article

References (33)

1. Brandes R.P., Schmitz-Winnenthal F., Feletou M., Godecke A., Huang P.L., Vanhoutte P.M., Fleming I., and Busse R. (2000) An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 9747-9752.
2. Campbell W.B., and Gauthier K.M. (2002) What is new in endothelium-derived hyperpolarizing factors? Current Opinion in Nephrology and Hypertension, 11, 177-183.
3. Carroll M.A., and McGiff J.C. (2000) A new class of lipid mediators: Cytochrome P450 arachidonate metabolites. Thorax, 55, S13-S16.
4. Chaytor A.T., Martin P.E.M., Edwards D.H., and Griffith T.M. (2001) Gap junction communication underpins EDHF-type relaxations evoked be ACh in the rat hepatic artery. American Journal of Physiology, 280, H2441-H2450.
5. Coppey L., Davidson E., Dunlap J., Lund D., and Yorek M. (2000) Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that provide circulation to the sciatic nerve. International Journal of Experimental Diabetes Research, 1, 131-143.
6. Coppey L., Gellett J., Davidson E., Dunlap J., Lund D., Salvemini D., and Yorek M. (2001) Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular function of epineurial arterioles of the sciatic nerve. British Journal of Pharmacology, 134, 121-129.
7. Coppey L., Gellett J., Davidson E., Dunlap J., Lund D., and Yorek M. (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50, 1927-1937.
8. Coppey L., Gellett J., Davidson E., Dunlap J., and Yorek M. (2002) Changes in epineurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diabetes/Metabolism Research and Reviews, 18, 1-9.
9. Cotter M.A., and Cameron N.E. (1997) Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats. Prostaglandins, Leukotrienes and Essential Fatty Acids, 56, 337-343.
10. De Vriese A.S., Van De Voorde J., Blom H.J., Vanhoutte P.M., Verbeke M., and Lameire N.H. (2000) The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia, 43, 1116-1125.
11. De Vriese A.S., Verbeuren T.J., Van De Voorde J., Lameire N.H., and Vanhoutte P.M. (2000) Endothelial dysfunction in diabetes. British Journal of Pharmacology, 130, 963-974.
12. Faraci F.M., and Heistad D.D. (1998) Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiology Review, 78, 53-97.
13. Fisslthaler B., Fleming I., and Busse R. (2000) EDHF: A cytochrome P450 metabolite in coronary arteries. Seminars in Perinatology, 24, 15-19.
14. Gebremedhin D., Harder D.R., Pratt P.F., and Campbell W.B. (1998) Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: Role of a cytochrome P450 metabolite. Journal of Vascular Research, 35, 274-284.
15. Giugliano D., Ceriello A., and Paolisso G. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care, 19, 257-267.
16. Hamilton C.A., McPhaden A.R., Berg G., Pathi B.V., and Dominiczak A.F. (2001) Is hydrogen peroxide an EDHF in human radial arteries? American Journal of Physiology, 280, H2451-H2455.
17. Hecker M. (2000) Endothelium-derived hyperpolarizing factor - Fact or fiction? News in Physiological Sciences, 15, 1-5.
18. Horrobin D.F. (1988) The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins, Leukotrienes and Essential Fatty Acids, 31, 181-197.
19. + release in isolated renal arteries of rats. British Journal of Pharmacology, 132, 1558-1564.
20. Makino A., Ohuchi K., and Kamata K. (2000) Mechanisms underlying the attenuation of endothelium-dependent vasodilation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. British Journal of Pharmacology, 130, 549-556.
21. Matoba T., Shimokawa H., Kubota H., Morikawa K., Fujiki T., Kunihiro I., Mukai Y., Hirakawa Y., and Takeshita A. (2002) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochemical Biophysical Research Communications, 290, 909-913.
22. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., Kanaide H., and Takeshita A. (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Journal of Clinical Investigation, 105, 1521-1530.
23. Peterson R.G., Shaw W.N., Neel M.A., Little L.A., and Eichberg, J. (1990) Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. Institute of Laboratory Animal Research News, 32, 16-19.
24. Pieper G. (2000) Hyperglycemia and diabetes-induced vascular dysfunction: Role of oxidative stress. In Oxidative Stress and Vascular Disease (ed. J. Keaney), Kluwer Academic, Boston, pp. 305-322.
25. Quignard J., Feletou M., Edwards G., Duhault J., Weston A.H., and Vanhoutte P.M. (2000) Role of endothelial cell hyperpolarization in EDHF-mediated responses in the guinea-pig carotid artery. British Journal of Pharmacology, 129, 1103-1112.
26. Quilley J., Fulton D., and McGiff J.C. (1997) Hyperpolarizing factors. Biochemical Pharmacology, 54, 1059-1070.
27. Stevens E.J., Lockett M.J., Carrington A.L., and Tomlinson D.R. (1993) Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia, 36, 397-401.
28. Taylor H.J., Chaytor A.T., Edwards D.H., and Griffith T.M. (2001) Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries. Biochemical Biophysical Research Communications, 283, 583-589.
29. Terata K., Coppey L., Davidson E., Dunlap J., Gutterman D., and Yorek M. (1999) Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. British Journal of Pharmacology, 128, 837-843.
30. Tomlinson D.R., Robinson J.P., Compton A.M., and Keen P. (1989) Essential fatty acid treatment-effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia, 32, 655-659.
31. Triggle C.R., and Ding H. (2002) Endothelium-derived hyperpolarizing factor: Is there a novel chemical mediator? Clinical Experimental Pharmacology and Physiology, 29, 153-160.
32. Vasquez-Perez S., Navarro-Cid J., Heras N., Cediel E., Sanz-Rosa D., Ruilope L.M., Cachofeiro V., and Lahera V. (2001) Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary artery. Journal of Hypertension, 19, 539-545.
33. Wigg S.J., Tare M., Tonta M.A., O'Brien R.C., Meredith I.T., and Parkington H.C. (2001) Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. American Journal of Physiology, 281, H232-H240.